Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2024-10-17 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Updates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, exercise price, changes in issued share capital, and compliance with SEBI regulations. There is no financial performance data, earnings information, or management discussion. The content focuses on the issuance and allotment of shares, which is a capital change event. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is about 4900 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement.
2024-10-17 English
ESOP Allotment
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, exercise price, changes in issued share capital, and compliance with SEBI regulations. There is no financial performance data, earnings information, or management discussion. The document is an announcement of a share issue related to employee stock options, which fits the category of Share Issue/Capital Change (SHA). The document length is about 4900 characters, and it contains detailed disclosure about the share allotment, not just a brief notice or a report publication announcement. Therefore, the appropriate classification is SHA with high confidence.
2024-10-17 English
Compliance -Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 for quarter and half year ended September 30, 2024
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialized/rematerialized for the quarter and half ended September 30, 2024. It is addressed to stock exchanges and signed by the company secretary and registrar agents. The document is short (3454 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to share dematerialization reporting. Therefore, it fits best under Regulatory Filings (RNS) as a compliance document rather than a financial report or announcement of a report.
2024-10-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialized/rematerialized for the quarter and half ended September 30, 2024. It is addressed to stock exchanges and signed by the company secretary and registrar agents. The document is short (3454 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to share dematerialization reporting. Therefore, it fits best under Regulatory Filings (RNS) as a compliance document rather than a financial report or announcement of a report.
2024-10-14 English
Investor/ Analyst Meet
Investor Presentation Classification · 85% confidence The document is a notification addressed to stock exchanges about upcoming meetings between the company's management and investors/analysts. It references Regulation 30 of the SEBI Listing Obligations, which pertains to disclosure of material events. The content is an intimation or announcement about an investor/analyst meet schedule, with no financial data, report, or detailed presentation included. The document length is short (1707 characters), and it does not contain any financial statements or detailed report content. Therefore, it is best classified as an Investor Presentation announcement or update. However, since it is only an intimation about the meeting and not the presentation itself, the closest fitting category is Investor Presentation (IP) as it relates to investor meetings and presentations.
2024-10-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated October 9, 2024, informing stock exchanges about upcoming meetings between the company's management and investors/analysts. It explicitly states it is an 'Intimation regarding the Analyst/Institutional Investor Meet' and mentions no unpublished price sensitive information will be shared. The document is brief (1707 characters) and serves as an announcement of a future event rather than a detailed report or presentation. It does not contain financial data, results, or detailed disclosures. According to the classification rules, such notices about investor meetings fall under Investor Presentation announcements or related updates. However, since this is only an intimation about the meeting schedule and not the presentation itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement under SEBI regulations and does not contain the actual presentation or detailed financial content. Confidence is high due to clear regulatory reference and document content.
2024-10-09 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.